Table 2.
Characteristics of acute kidney injury alerts generated in the SunRise Clinical Manager electronic medication record from the silent alert phase on 14 medical and surgical hospital units in the Calgary Zone over a 30 day observation period
| Alert Frequency | Number (%) |
|---|---|
| Total AKI alerts | 81 (100.0) |
| Stage 1 AKI alerts | 54 (66.7) |
| Stage 2 AKI alerts | 14 (17.3) |
| Stage 3 AKI alerts | 13 (16.0) |
| Active medications included in AKI alerts | 36 (44.4) |
| Diuretics | 19 (23.4) |
| Antibiotics | 1 (1.2) |
| ACE-I/ARB | 10 (12.3) |
| NSAIDs | 6 (7.4) |
| Patient location where AKI alert generated | |
| Medical unit | 66 (81.5) |
| Surgical unit | 15 (18.5) |
AKI acute kidney injury, ACE-I angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, NSAID non-steroidal anti-inflammatory drugs